HomeIMMNOV • STO
add
Immunovia AB (publ)
Previous close
kr 0.40
Day range
kr 0.38 - kr 0.40
Year range
kr 0.38 - kr 3.15
Market cap
101.30M SEK
Avg Volume
2.70M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 455.00K | 191.67% |
Operating expense | 30.62M | 29.68% |
Net income | 3.07M | 106.26% |
Net profit margin | 674.73 | 102.15% |
Earnings per share | — | — |
EBITDA | -28.89M | -37.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.32M | -67.03% |
Total assets | 33.04M | -66.52% |
Total liabilities | 21.39M | -32.49% |
Total equity | 11.65M | — |
Shares outstanding | 261.91M | — |
Price to book | 5.75 | — |
Return on assets | -156.90% | — |
Return on capital | -287.77% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 3.07M | 106.26% |
Cash from operations | -28.28M | 0.74% |
Cash from investing | — | — |
Cash from financing | -1.04M | 36.46% |
Net change in cash | -28.89M | 3.36% |
Free cash flow | -19.48M | 18.38% |
About
Founded
2007
Website
Employees
9
